Mandate

Lendify has secured new financing of up to SEK 1,500,000,000 from, amongst others, Insight Investment

June 11, 2019 Banking and Finance

Together with, amongst others, the management of the company, the arranger and legal advisors to the arranger, Vinge has acted for Lendify in the structuring, documenting and execution of the transaction where one of the world’s largest and most well established asset managers, Insight Investment, acted as main investor.

The transaction is one of the first in Sweden to be executed and reported under the new EU securitisation regulation (Regulation (EU) 2017/2402 of the European Parliament and of the Council of 12 December 2017) and to be subject to the new reporting requirements thereunder.

Lendify has, with Vinge’s assistance, secured financing of approximately SEK 2,800,000,000 during the spring of 2019, primarily by completion of the above mentioned transaction, by completion of the transaction with a large Swedish institution previously announced in February and by establishing a credit facility with Nordea.

Vinge’s team mainly consisted of partner Albert Wållgren, associates Lionardo Ojeda and Axel Jansson (Banking and Finance) and partner Emma Stuart Beck and associate Caroline Krassén (Financial Services).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026